• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用比较功能基因组学来确定用于研究人类癌症的最佳匹配小鼠模型。

Application of comparative functional genomics to identify best-fit mouse models to study human cancer.

作者信息

Lee Ju-Seog, Chu In-Sun, Mikaelyan Arsen, Calvisi Diego F, Heo Jeonghoon, Reddy Janardan K, Thorgeirsson Snorri S

机构信息

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4262, USA.

出版信息

Nat Genet. 2004 Dec;36(12):1306-11. doi: 10.1038/ng1481. Epub 2004 Nov 21.

DOI:10.1038/ng1481
PMID:15565109
Abstract

Genetically modified mice have been extensively used for analyzing the molecular events that occur during tumor development. In many, if not all, cases, however, it is uncertain to what extent the mouse models reproduce features observed in the corresponding human conditions. This is due largely to lack of precise methods for direct and comprehensive comparison at the molecular level of the mouse and human tumors. Here we use global gene expression patterns of 68 hepatocellular carcinomas (HCCs) from seven different mouse models and 91 human HCCs from predefined subclasses to obtain direct comparison of the molecular features of mouse and human HCCs. Gene expression patterns in HCCs from Myc, E2f1 and Myc E2f1 transgenic mice were most similar to those of the better survival group of human HCCs, whereas the expression patterns in HCCs from Myc Tgfa transgenic mice and in diethylnitrosamine-induced mouse HCCs were most similar to those of the poorer survival group of human HCCs. Gene expression patterns in HCCs from Acox1(-/-) mice and in ciprofibrate-induced HCCs were least similar to those observed in human HCCs. We conclude that our approach can effectively identify appropriate mouse models to study human cancers.

摘要

转基因小鼠已被广泛用于分析肿瘤发生过程中出现的分子事件。然而,在许多(即便不是所有)情况下,尚不确定小鼠模型在多大程度上重现了在相应人类病症中观察到的特征。这在很大程度上是由于缺乏在分子水平上对小鼠和人类肿瘤进行直接和全面比较的精确方法。在此,我们利用来自七种不同小鼠模型的68例肝细胞癌(HCC)以及来自预定义亚类的91例人类HCC的全局基因表达模式,以直接比较小鼠和人类HCC的分子特征。Myc、E2f1和Myc E2f1转基因小鼠的HCC中的基因表达模式与人类HCC中生存率较高组的最为相似,而Myc Tgfa转基因小鼠的HCC以及二乙基亚硝胺诱导的小鼠HCC中的表达模式与人类HCC中生存率较低组的最为相似。Acox1(-/-)小鼠的HCC以及环丙贝特诱导的HCC中的基因表达模式与在人类HCC中观察到的最不相似。我们得出结论,我们的方法能够有效地识别出用于研究人类癌症的合适小鼠模型。

相似文献

1
Application of comparative functional genomics to identify best-fit mouse models to study human cancer.应用比较功能基因组学来确定用于研究人类癌症的最佳匹配小鼠模型。
Nat Genet. 2004 Dec;36(12):1306-11. doi: 10.1038/ng1481. Epub 2004 Nov 21.
2
Comparative functional genomics for identifying models of human cancer.用于识别人类癌症模型的比较功能基因组学
Carcinogenesis. 2005 Jun;26(6):1013-20. doi: 10.1093/carcin/bgi030. Epub 2005 Jan 27.
3
Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer.整合基因组比较揭示了小鼠模型与人肝癌的临床相似性。
Mol Cancer Res. 2018 Nov;16(11):1713-1723. doi: 10.1158/1541-7786.MCR-18-0313. Epub 2018 Aug 6.
4
Etiology-dependent molecular mechanisms in human hepatocarcinogenesis.人类肝癌发生中病因依赖的分子机制。
Hepatology. 2008 Feb;47(2):511-20. doi: 10.1002/hep.22033.
5
Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.酰基辅酶A氧化酶缺陷小鼠自发发生的肝细胞癌的分子谱分析:与过氧化物酶体增殖剂和遗传毒性致癌物诱导的野生型小鼠肝肿瘤的比较。
Carcinogenesis. 2003 May;24(5):975-84. doi: 10.1093/carcin/bgg040.
6
Frequent trefoil factor 3 (TFF3) overexpression and promoter hypomethylation in mouse and human hepatocellular carcinomas.频繁三叶因子3(TFF3)在小鼠和人类肝细胞癌中过表达及启动子低甲基化。
Int J Oncol. 2005 Feb;26(2):369-77.
7
[Comparative genomic classification of human hepatocellular carcinoma].[人类肝细胞癌的比较基因组分类]
Magy Onkol. 2009 Mar;53(1):61-7. doi: 10.1556/MOnkol.53.2009.1.9.
8
Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.联合血清和组织蛋白质组学研究应用于 c-Myc 转基因肝癌小鼠模型,鉴定出适合诊断和治疗干预策略的新型疾病调控蛋白。
J Proteome Res. 2011 Jul 1;10(7):3012-30. doi: 10.1021/pr101207t. Epub 2011 Jun 6.
9
Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis.肝癌中蛋氨酸代谢改变与全基因组DNA甲基化:与基因组不稳定及预后的关系
Int J Cancer. 2007 Dec 1;121(11):2410-20. doi: 10.1002/ijc.22940.
10
Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography.β-连环蛋白基因突变激活的肝细胞癌需要胆碱,并可通过正电子发射断层扫描检测。
Gastroenterology. 2019 Sep;157(3):807-822. doi: 10.1053/j.gastro.2019.05.069. Epub 2019 Jun 10.

引用本文的文献

1
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.肝癌类器官在肿瘤精准医学中的应用:一项综述
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
2
Carbohydrate-Responsive Element-Binding Protein-Associated Metabolic Changes in Chemically Induced Hepatocarcinogenesis Mouse Model.化学诱导肝癌发生小鼠模型中碳水化合物反应元件结合蛋白相关的代谢变化
Int J Mol Sci. 2025 Jul 18;26(14):6932. doi: 10.3390/ijms26146932.
3
Hepatic Metabolic Signature and Its Association with the Response to Immunotherapy in Hepatocellular Carcinoma.
肝细胞癌的肝脏代谢特征及其与免疫治疗反应的关联
Immunotargets Ther. 2025 Jul 23;14:787-798. doi: 10.2147/ITT.S491464. eCollection 2025.
4
Progression to fibrosis and hepatocellular carcinoma in DEN CCl liver mice, is associated with macrophage and striking regulatory T cells infiltration.在二乙基亚硝胺(DEN)-四氯化碳(CCl)诱导的肝纤维化小鼠模型中,向纤维化和肝细胞癌的进展与巨噬细胞及显著的调节性T细胞浸润有关。
Front Immunol. 2025 Jul 8;16:1601215. doi: 10.3389/fimmu.2025.1601215. eCollection 2025.
5
Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis.桥粒斑蛋白介导的细胞骨架串扰作为抑制肝细胞癌生长和转移的靶点
Elife. 2025 Mar 7;13:RP102205. doi: 10.7554/eLife.102205.
6
In Vivo CRISPR Activation Screening Reveals Chromosome 1q Genes VPS72, GBA1, and MRPL9 Drive Hepatocellular Carcinoma.体内CRISPR激活筛选揭示1号染色体上的基因VPS72、GBA1和MRPL9驱动肝细胞癌。
Cell Mol Gastroenterol Hepatol. 2025;19(5):101460. doi: 10.1016/j.jcmgh.2025.101460. Epub 2025 Jan 4.
7
DNAJB4/HLJ1 deficiency sensitizes diethylnitrosamine-induced hepatocarcinogenesis with peritumoral STAT3 activation.DNAJB4/HLJ1缺陷通过肿瘤周围STAT3激活使二乙基亚硝胺诱导的肝癌发生敏感化。
Cell Biol Toxicol. 2024 Dec 30;41(1):20. doi: 10.1007/s10565-024-09978-y.
8
Unveiling the physiological impact of ESCRT-dependent autophagosome closure by targeting the VPS37A ubiquitin E2 variant-like domain.通过靶向VPS37A泛素E2变体样结构域揭示内体分选转运复合体(ESCRT)依赖性自噬体封闭的生理影响。
Cell Rep. 2024 Dec 24;43(12):115016. doi: 10.1016/j.celrep.2024.115016. Epub 2024 Nov 27.
9
Identification of MYC genes in four Cucurbitaceae species and their roles in the response to temperature stress.鉴定四种葫芦科植物中的 MYC 基因及其在温度胁迫响应中的作用。
BMC Genomics. 2024 Sep 16;25(1):867. doi: 10.1186/s12864-024-10771-8.
10
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial.预测肝细胞癌患者对阿替利珠单抗联合贝伐珠单抗免疫治疗反应的基因组生物标志物:来自 IMbrave150 试验的见解。
Clin Mol Hepatol. 2024 Oct;30(4):807-823. doi: 10.3350/cmh.2024.0333. Epub 2024 Jul 23.